Phase 1b Safety Study of IMSB301 in Type 1 Interferonopathies

Clinical trial NCT07364513 · RECRUITING

Trial details

NCT number: NCT07364513
Sponsor: ImmuneSensor Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Type 1 Interferonopathies

Start date: 2026-01-12
Primary completion: 2026-07-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.